246 related articles for article (PubMed ID: 37152956)
1. A bibliometric and visualized research on global trends of immune checkpoint inhibitors related complications in melanoma, 2011-2021.
Zhang H; Shi Y; Ying J; Chen Y; Guo R; Zhao X; Jia L; Xiong J; Jiang F
Front Endocrinol (Lausanne); 2023; 14():1164692. PubMed ID: 37152956
[TBL] [Abstract][Full Text] [Related]
2. Research hot spots and trends in endocrine-related adverse events caused by immune checkpoint inhibitors: a bibliometric analysis and visualization research.
Zhao J; Liu G; Yang X; Zhang C; Han B; Jiang M
Front Endocrinol (Lausanne); 2024; 15():1253832. PubMed ID: 38686201
[TBL] [Abstract][Full Text] [Related]
3. Bibliometric analysis of rheumatic immune related adverse events associated with immune checkpoint inhibitors.
Zeng L; Ma G; Chen K; Zhou Q
Front Immunol; 2023; 14():1242336. PubMed ID: 37869006
[TBL] [Abstract][Full Text] [Related]
4. Research Trends in Immune Checkpoint Blockade for Melanoma: Visualization and Bibliometric Analysis.
Xu Y; Jiang Z; Kuang X; Chen X; Liu H
J Med Internet Res; 2022 Jun; 24(6):e32728. PubMed ID: 35759331
[TBL] [Abstract][Full Text] [Related]
5. Immune-related adverse events: A bibliometric analysis.
Jiang ST; Liu YG; Zhang L; Sang XT; Xu YY; Lu X
Front Immunol; 2022; 13():1096806. PubMed ID: 36591239
[TBL] [Abstract][Full Text] [Related]
6. Knowledge mapping and current trends of immunotherapy for prostate cancer: A bibliometric study.
Zhong W; Shen Z; Wu Y; Mao X; Kong J; Wu W
Front Immunol; 2022; 13():1014981. PubMed ID: 36389756
[TBL] [Abstract][Full Text] [Related]
7. Global research trends on the links between gut microbiota and cancer immunotherapy: A bibliometric analysis (2012-2021).
Yang S; Zhao S; Ye Y; Jia L; Lou Y
Front Immunol; 2022; 13():952546. PubMed ID: 36090978
[TBL] [Abstract][Full Text] [Related]
8. Bibliometric analysis of research trends on the combination of immune checkpoint inhibitors and PARP inhibitors in solid tumors.
Tan Y; Song Q
Heliyon; 2024 Jan; 10(2):e24452. PubMed ID: 38293546
[TBL] [Abstract][Full Text] [Related]
9. Knowledge structure and hotspots research of glioma immunotherapy: a bibliometric analysis.
Yuan Y; Su Y; Wu Y; Xue Y; Zhang Y; Zhang Y; Zheng M; Chang T; Qu Y; Zhao T
Front Oncol; 2023; 13():1229905. PubMed ID: 37671057
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy for ocular melanoma: a bibliometric and visualization analysis from 1991 to 2022.
Tan Y; Lu Y; Chen S; Zou C; Qin B
Front Oncol; 2023; 13():1161759. PubMed ID: 37324010
[TBL] [Abstract][Full Text] [Related]
11. Mapping the intellectual structure and landscape of colorectal cancer immunotherapy: A bibliometric analysis.
Ou QL; Chang YL; Liu JH; Yan HX; Chen LZ; Guo DY; Zhang SF
Hum Vaccin Immunother; 2024 Dec; 20(1):2323861. PubMed ID: 38497584
[TBL] [Abstract][Full Text] [Related]
12. Research Trends in the Application of Artificial Intelligence in Oncology: A Bibliometric and Network Visualization Study.
Wu T; Duan Y; Zhang T; Tian W; Liu H; Deng Y
Front Biosci (Landmark Ed); 2022 Aug; 27(9):254. PubMed ID: 36224012
[TBL] [Abstract][Full Text] [Related]
13. Immune regulation and the tumor microenvironment in anti-PD-1/PDL-1 and anti-CTLA-4 therapies for cancer immune evasion: A bibliometric analysis.
Huang Y; Chen Z; Shen G; Fang S; Zheng J; Chi Z; Zhang Y; Zou Y; Gan Q; Liao C; Yao Y; Kong J; Fan X
Hum Vaccin Immunother; 2024 Dec; 20(1):2318815. PubMed ID: 38419524
[TBL] [Abstract][Full Text] [Related]
14. Emerging trends of BCG immunotherapy for bladder cancer in last decade: a bibliometric and visualization analysis.
Chen X; He F; Zhang W; Fu Y; Cao Z
Front Oncol; 2023; 13():1092969. PubMed ID: 37124495
[TBL] [Abstract][Full Text] [Related]
15. Bibliometric analysis of global research trends on male osteoporosis: a neglected field deserves more attention.
Wu H; Sun Z; Tong L; Wang Y; Yan H; Sun Z
Arch Osteoporos; 2021 Oct; 16(1):154. PubMed ID: 34632530
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine Kinase Inhibitors for Renal Cell Carcinoma: A Bibliometric Analysis via CiteSpace from 2000 to 2022.
Xu J; Huang Z; Gao S; Deng G; Di J
Urol Int; 2023; 107(8):755-771. PubMed ID: 37454653
[TBL] [Abstract][Full Text] [Related]
17. Knowledge mapping of targeted immunotherapy for myasthenia gravis from 1998 to 2022: A bibliometric analysis.
Su Y; Ruan Z; Wang R; Hao S; Tang Y; Huang X; Gao T; Li Z; Chang T
Front Immunol; 2022; 13():998217. PubMed ID: 36248874
[TBL] [Abstract][Full Text] [Related]
18. Emerging trends and focus on immune checkpoint inhibitors for non-small cell lung cancer treatment: visualization and bibliometric analysis.
Zhang Y; Lu L; Zheng R
Front Pharmacol; 2023; 14():1140771. PubMed ID: 37214445
[No Abstract] [Full Text] [Related]
19. Mapping knowledge landscapes and emerging trends of the biomarkers in melanoma: a bibliometric analysis from 2004 to 2022.
Wan Y; Shen J; Hong Y; Liu J; Shi T; Cai J
Front Oncol; 2023; 13():1181164. PubMed ID: 37427124
[TBL] [Abstract][Full Text] [Related]
20. Worldwide research trends on tumor burden and immunotherapy: a bibliometric analysis.
Zhang L; Zheng H; Jiang ST; Liu YG; Zhang T; Zhang JW; Lu X; Zhao HT; Sang XT; Xu YY
Int J Surg; 2024 Mar; 110(3):1699-1710. PubMed ID: 38181123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
